๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mitral Regurgitation
Clinical trial register · China

Mitral Regurgitation Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 4 Guangzhou 3 Shenyang 2 Suzhou 2 Nanjing 1
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing4 Guangzhou3 Shenyang2 Suzhou2 Nanjing1
All 11 locations
Target enrolment
to

Mitral Regurgitation trials in China

15 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease
NCT07605624Aortic Stenosis, Aortic Regurgitation, Mitral Regurgitation, Tricuspid Regurgitation
Beijing Anzhen Hospital
Observational
5,500
Beijing
2026-05-10
Active, closed
Artificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair
NCT07632794Mitral Regurgitation
Mi Chen
Observational
1,500
Beijing
2025-09-01
Recruiting
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant
NCT07007143Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4
1,032
Beijing
2025-07-31
Recruiting
STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients With an Indication for Oral Anticoagulant
NCT06901466Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital
Phase 4
880
Beijing
2025-06-13
Recruiting
Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).
NCT07055919Mitral R, Mitral Regurgitation
Xiamen Cardiovascular Hospital, Xiamen University
Not applicable
112
Xiamen
2025-03-22
Not yet open
CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair
NCT06814210Mitral Regurgitation, Functional Mitral Regurgitation, Degenerative Mitral Valve Regurgitation
Xiao-dong Zhuang
Not applicable
120
Guangzhou
2025-03-01
Recruiting
The Multi-center Study of Comprehensive Atrial Fibrillation Regurgitation and Recurrent Events Evaluation
NCT07085650Atrial Fibrillation (AF), Mitral Regurgitation, Tricuspid Regurgitation
First Hospital of China Medical University
Observational
2,000
Shenyang
2024-12-30
Not yet open
Concomitant Tricuspid Repair in Patients With Left Heart Surgery
NCT05595187Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
400
Nanjing
2024-05-01
Recruiting
Comparison of Transcatheter Edge-to-edge Repair Using Echo Only with Echo Combined with X Ray for Mitral Regurgitation (ECHO-CLIP)
NCT06684171Mitral Regurgitation
Pan Xiangbin
Not applicable
200
Shenzhen
2024-03-29
Not yet open
Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER)
NCT06227286Mitral Regurgitation
Sun Yat-sen University
Not applicable
176
Guangzhou, Jieyang, Shantou, Zhongshan
2024-03-01
Recruiting
TEER for Severe DMR of Low to Intermediate Surgery Risk
NCT06162780Mitral Regurgitation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
160
Guangzhou
2024-01-01
Recruiting
Safety and Efficacy of the GeminiOne Transcatheter Valve Edge-to-Edge Repair System in Patients With Moderate-severe or Severe Degenerative Mitral Regurgitation
NCT05655897Mitral Regurgitation, Degenerative Mitral Valve Disease
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
120
Suzhou
2022-11-24
Recruiting
Safety and Efficacy of the HighLife Transcatherter Mitral Valve Replacement System in Patients With Moderate-severe or Severe Mitral Regurgitation in China
NCT05610566Mitral Regurgitation
Peijia Medical Technology (Suzhou) Co., Ltd.
Not applicable
110
Suzhou
2022-07-06
Recruiting
Valveclipยฎ Transcatheter Mitral Valve Repair Study
NCT05021614Mitral Regurgitation
Shanghai NewMed Medical Co., Ltd.
Not applicable
150
Sichuan
2021-09-24
Recruiting
SQ-Kyrin TMVr FIM Study
NCT05040074Mitral Regurgitation
Shanghai Shenqi Medical Technology Co., Ltd
Not applicable
20
Shenyang
2021-04-01
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/condition/mitral-regurgitation

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies listing the condition Mitral Regurgitation.

How many Mitral Regurgitation trials are recruiting in China?

10 of the 15 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 4 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mitral Regurgitation), 15 studies
PhaseStudiesRecruitingShare
Not applicable9660%
Observational4226.7%
Phase 42213.3%

Most active sponsors

Lead sponsors with the most studies (Mitral Regurgitation)
Lead sponsorStudiesRecruiting
Chinese Academy of Medical Sciences, Fuwai Hospital22
Peijia Medical Technology (Suzhou) Co., Ltd.22
Beijing Anzhen Hospital10
First Hospital of China Medical University11
Mi Chen10
Nanjing Medical University10
Pan Xiangbin11
Shanghai NewMed Medical Co., Ltd.11
Shanghai Shenqi Medical Technology Co., Ltd11
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.